Back to Search
Start Over
Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab′)2-mediated anti-complement activity.
- Source :
- Clinical & Experimental Immunology; Oct1997, Vol. 110 Issue 1, p122-126, 5p
- Publication Year :
- 1997
-
Abstract
- Xenotransplantation between discordant species leads to a hyperacute rejection mediated by natural antibodies. both of the IgG and IgM isotypes, activation of complement and endothelial cell activation. The combination of these mechanisms leads to a transplant survival of minutes to a few hours. Polyclonal human irnmunoglobulins for intravenous use ([V]g) from normal donors have proved effective in a number of antibody-mediated disorders, as well as in inflammatory disorders. We demonstrate that administration of [V]g in a guinea pig to rat model of cardiac xenografting can effectively delay hyperacute rejection. This effect is mediated by the F(ab')<subscript>2</subscript> fragments of [V]g. and is correlated to an anti-complementary activity. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00099104
- Volume :
- 110
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Clinical & Experimental Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 15898042
- Full Text :
- https://doi.org/10.1111/j.1365-2249.1997.459-ce1358.x